HPSE and Sepsis: Notably, the CLP+UFH+HPA inhibitor group exhibited a significantly greater increase in AT-III activity than the groups treated with UFH or the HPA inhibitor alone (P < 0.05), suggesting an additive effect of UFH and HPA inhibition in restoring anticoagulant function during sepsis.